Indacaterol

Back to search

Molecule Structure

Scientific Name

Indacaterol

Description of the Drug

Indacaterol is an inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB05039

Brand Name(s)

Not Available

Company Owner(s)

Novartis Pharmaceuticals Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Beta-2 adrenergic receptor SINGLE PROTEIN AGONIST CHEMBL210

Unichem Links

SureChEMBL SCHEMBL48098
PharmGKB PA165958348
Human Metabolome Database HMDB0015608
DrugBank DB05039
PubChem: Thomson Pharma 15126362 14805326
PubChem 6918554
LINCS LSM-45506
Nikkaji J2.407.733K
EPA CompTox Dashboard DTXSID90185198
DrugCentral 4183
ChemicalBook CB82512068 CB72566367
Guide to Pharmacology 7455
GSRS 991a568b-ec78-48b7-9994-07c79d708cfe
rxnorm INDACATEROL MALEATE INDACATEROL
ChEBI 68575
ZINC ZINC000035801098